Company / Current Liabilities per Share
ARS Pharmaceuticals, Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.40
FY2025
5-year range
$0.03 / $0.40
FY2021-FY2025
Trend
+64.4%
vs FY2024
Sector context
#163 of 210
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s current liabilities per share of $0.40 is lower than 78% of companies in the Health Care sector (FY2025). Increased from $0.03 to $0.40 over the past 2 years.
Based on SEC 10-K filings.
0.40 in FY2025 with a 5-year CAGR of -34.5%.
Increased from $0.03 to $0.40 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +30.6%
- 5-Year CAGR
- -34.5%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 210This company $0.40 Sector average $23.79
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 64.4% year-over-year.
- Ranks #163 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.40 | +64.4% |
| FY2024 | $0.24 | +855.2% |
| FY2023 | $0.03 | -85.8% |
| FY2022 | $0.18 | -36.8% |
| FY2021 | $0.28 | -91.4% |
| FY2020 | $3.30 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026